Business
Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading Companies - Gilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More
Technological advances and growing investments in stem cell research by private entities and governments enhance therapeutic production while reducing costs, fueling market growth and adoption Stem Cell and Regenerative Therapy Market Stem Cell and Regenerative Therapy Market Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Stem Cell and Regenerative Therapy: Global Markets" has been added to ResearchAndMarkets.com's offering. The global stem cell and regenerative therapy market is poised for subs
About this update from Gilead Sciences, Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Technological advances and growing investments in stem cell research by private entities and governments enhance therapeutic production while reducing costs, fueling market growth and adoption","length":192,"tagName":"p"},{"type":"text","content":"Stem Cell and Regenerative Therapy Market","length":41,"tagName":"p"},{"type":"image","alt":"Stem Cell and Regenerative Therapy Market","displaySize":"","headline":null,"caption":"Stem Cell and Regenerative Therapy Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/cfb994340541e3951809ff5ac51995b6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gEfJHCNdSu9eohRzExujxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/cfb994340541e3951809ff5ac51995b6","width":600,"height":400}}},{"type":"text","content":"Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Stem Cell and Regenerative Therapy: Global Markets" has been added to ResearchAndMarkets.com's offering.","length":166,"tagName":"p"},{"type":"text","content":"The global stem cell and regenerative therapy market is poised for substantial growth, with projections indicating an increase from $16.7 billion in 2025 to $43.8 billion by 2030, reflecting a compound annual growth rate (CAGR) of 21.3%. This burgeoning sector is driven by its potential to address chronic and challenging health conditions, including cancer, Parkinson's, Alzheimer's, diabetes, and cardiovascular diseases.","length":432,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/4d3225a72f38bcdb2e247db4710...